Antibiotic Resistance and Virulence Gene Profiling of Uropathogenic Escherichia coli Isolated from Clinical Samples

ORIGINAL ARTICLE
Zahraa F. Al-Kabi, Hasan A. Aal Owaif

 
For citation: Al-Kabi ZF, Aal Owaif HA. Antibiotic Resistance and Virulence Gene Profiling of Uropathogenic Escherichia coli Isolated from Clinical Samples. International Journal of Biomedicine. 2025;15(1):188-191. doi:10.21103/Article15(1)_OA23
 
Originally published March 5, 2025

Abstract: 

Background: Urinary tract infection (UTI) is the third most prevalent type of infection, following respiratory and gastrointestinal infections. Uropathogenic E. coli (UPEC) is a subset of extraintestinal pathogenic E. coli with a wide range of genotypes responsible for causing UTIs. This study aimed to detect the antibiotic resistance and virulence genes of local isolates of UPEC from UTIs and to determine biofilm formation by UPEC isolates.
Methods and Results: One hundred urine samples were obtained from patients with UTIs from hospitals in Baghdad from September 2023 to December 2023 and then plated for 24 hours at 37°C on McConkey agar. Biochemical tests and the VITEK-2 system were used to identify UPEC isolates. The antibiotic susceptibility test was performed using the disc diffusion technique, and the results were identified according to the guidelines of CLSI 2023. The biofilm formation was determined by an ELISA reader at OD570 using the microtitre-plate technique. Detection of csgA and fimH genes was performed by PCR.
Fifty-two (52%) isolates of UPEC were identified from 100 urine samples.  The results revealed that 100% of the isolates were resistant to ceftazidime, 92.3% to gentamicin, 90.4% to ciprofloxacin, 84.6% to azithromycin and aztreonam, and 46.1% to imipenem. Out of 52 isolates, 39(75%) have multiple resistance to more than three antibiotics. The results demonstrated that 12% of the isolates were strong biofilm producers, 40% - moderate biofilm producers, 36% produced weak biofilms, and 12% did not produce biofilms. The csgA and fimH genes were detected in 47(90%) and 49(94%) isolates, respectively.
Conclusion: This study demonstrated that elevated resistance rates were noted against administered antibiotics, signifying an increasing problem in effectively treating UTIs; 75% of the isolates showed an MDR phenotype. The study also verified the capacity of UPEC to produce biofilms (88% of isolates) and express virulence factors, enhancing their pathogenicity and treatment resistance.

Keywords: 
Uropathogenic E. coli • antibiotic resistance • biofilm • virulence genes
References: 
  1. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary Tract Infections: The Current Scenario and Future Prospects. Pathogens. 2023 Apr 20;12(4):623. doi: 10.3390/pathogens12040623. PMID: 37111509; PMCID: PMC10145414.
  2. Lee HS, Le J. Urinary tract infections. In: Huang V, et al., editors. Infectious diseases. PSAP 2018 Book.
  3. Mohapatra S, Panigrahy R, Tak V, J V S, K C S, Chaudhuri S, Pundir S, Kocher D, Gautam H, Sood S, Das BK, Kapil A, Hari P, Kumar A, Kumari R, Kalaivani M, R A, Salve HR, Malhotra S, Kant S. Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 2022 Feb 9;4(2):000321. doi: 10.1099/acmi.0.000321. PMID: 35355869; PMCID: PMC8941965.
  4. Jalil MB, Al Atbee MYN. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. J Clin Lab Anal. 2022 Sep;36(9):e24619. doi: 10.1002/jcla.24619. Epub 2022 Jul 23. PMID: 35870190; PMCID: PMC9459318.
  5. Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, Huang Y, Chi M. Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options. Int J Mol Sci. 2023 Jun 23;24(13):10537. doi: 10.3390/ijms241310537. PMID: 37445714; PMCID: PMC10341809.
  6. Aal Owaif HA, Mhawesh AA, Abdulateef SA. The role of BipA in the regulation of K1 capsular polysaccharide production of uropathogenic Escherichia coli. Ann Trop Med Public Health. 2019;22 (Special Issue):S254. doi: 10.36295/ASRO.2019.220924.
  7. Denise R, Abby SS, Rocha EPC. The Evolution of Protein Secretion Systems by Co-option and Tinkering of Cellular Machineries. Trends Microbiol. 2020 May;28(5):372-386. doi: 10.1016/j.tim.2020.01.005. Epub 2020 Feb 13. PMID: 32298615.
  8. Owaif HAA, Aldulaimy MK, Abdulateef SA. The Antibiotic Resistance Genes blaSHV, blaOXA-48, blaTEM and blaIMP in Pseudomonas aeruginosa Isolated from Respiratory Tract Infections in Baghdad, Iraq. International Journal of Biomedicine.2023;13(4):341-344. doi:10.21103/Article13(4) _OA18.
  9. Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms. 2023 Jun 19;11(6):1614. doi: 10.3390/microorganisms11061614. Erratum in: Microorganisms. 2024 Sep 27;12(10):1961. doi: 10.3390/microorganisms12101961. PMID: 37375116; PMCID: PMC10305407.
  10. Mohamud MHT, Mohamed YO, Shaba AA, Elmi SN, Hassan AS, Mohamoud MA, Abdikadir MO. Bacterial uropathogens in urinary tract infections and antibiotic susceptibility patterns in Banadir Hospital, Mogadishu. Androl Gynecol Curr Res. 2019;7:2. doi:10.4172/2327-4360.1000171.
  11. Boroumand M, Sharifi A, Ghatei MA, Sadrinasab M. Evaluation of biofilm formation and virulence genes and association with antibiotic resistance patterns of uropathogenic Escherichia coli strains in southwestern Iran. Jundishapur J Microbiol. 2021;14(9),e117785. doi:10.5812/JJM.117785.
  12. Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging health. 2013 Oct;9(5):10.2217/ahe.13.38. doi: 10.2217/ahe.13.38. PMID: 24391677; PMCID: PMC3878051.
  13. Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, Heidary M, Khoshnood S. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. PMID: 36620240; PMCID: PMC9815622.
  14. Bullens M, de Cerqueira Melo A, Raziq S, Lee J, Khalid GG, Khan SN, Zada A; Atta-Ur-Rehman; Wailly Y, Zeshan SM, Saad NJ, Gil-Cuesta J, Williams A. Antibiotic resistance in patients with urinary tract infections in Pakistan. Public Health Action. 2022 Mar 21;12(1):48-52. doi: 10.5588/pha.21.0071. PMID: 35317540; PMCID: PMC8908872.
  15. Adamus-Białek W, Baraniak A, Wawszczak M, Głuszek S, Gad B, Wróbel K, Bator P, Majchrzak M, Parniewski P. The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Mol Biol Rep. 2018 Oct;45(5):1055-1065. doi: 10.1007/s11033-018-4254-0. Epub 2018 Jul 14. PMID: 30008141; PMCID: PMC6156760.
  16. Ajayi AO, Osanyinlusi SA, Ogeneh B, Ojerinde OA, Oladeji SJ. Antibiotic resistance patterns among gram-negative bacteria from patients with urinary tract infections at a healthcare center in Ado-ekiti, Nigeria. Am J Microbiol Res. 2019;7(2):37–44. doi:10.12691/ajmr-7-2-1.
  17. Wohlgemuth I, Garofalo R, Samatova E, Günenç AN, Lenz C, Urlaub H, Rodnina MV. Translation error clusters induced by aminoglycoside antibiotics. Nat Commun. 2021 Mar 23;12(1):1830. doi: 10.1038/s41467-021-21942-6. PMID: 33758186; PMCID: PMC7987974.
  18. Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016 Jan-Jun;7(1):22-6. doi: 10.4103/0976-9668.175020. PMID: 27003964; PMCID: PMC4780161.
  19. Mhawesh A, Aal Owaif HA, Abdulateef S. In vitro experimental research for using the silver nanoparticles as plasmid curing agent in some types of multi-antibiotic resistant pathogenic bacteria. Indian J Public Health Res Dev.2019;10(8):2448–54. doi: 10.5958/0976-5506.2019. 02233.2.
  20. Hasan SA, Najati AM, Abass KS. Prevalence and antibiotic resistance of Pseudomonas aeruginosa isolated from clinical samples in Kirkuk City, Iraq. Eurasia J Biosci. 2020;14(1):1821-1825.
  21. Abdulateef SA, Al-Salmani MS, Aal Owaif HA. Acinetobacter baumannii producing ESBLs and carbapenemases in the Intensive Care Units developing fosfomycin and colistin resistance. Journal of Applied and Natural Science. 2023;15(3):1263-1267. doi:10.31018/jans.v15i3.4872.
  22. Naziri Z, Derakhshandeh A, Soltani Borchaloee A, Poormaleknia M, Azimzadeh N. Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Escherichia coli. Infect Drug Resist. 2020 Jun 17;13:1839-1850. doi: 10.2147/IDR.S256131. PMID: 32606833; PMCID: PMC7306463.
  23. Khambhati K, Patel J, Saxena V, A P, Jain N. Gene Regulation of Biofilm-Associated Functional Amyloids. Pathogens. 2021 Apr 19;10(4):490. doi: 10.3390/pathogens10040490. PMID: 33921583; PMCID: PMC8072697.
  24. Abed AD, Mutter TY. Relationship between antimicrobial resistance and virulence factors in uropathogenic Escherichia coli isolates from Ramadi, Iraq: phenotype and genotype identification. Afr Health Sci. 2023 Sep;23(3):486-496. doi: 10.4314/ahs.v23i3.56. PMID: 38357165; PMCID: PMC10862563.
  25. Al-Dulaymi AAA-M, Aal Owaif HA. Overexpression of lasB gene in Klebsiella pneumoniae and its effect on biofilm formation and antibiotic resistance. Al-Rafidain J Med Sci. 2024;6(2):3–8. doi:10.54133/ajms.v6i2.668.
  26. Yekani M, Memar MY, Alizadeh N, Safaei N, Ghotaslou R. Antibiotic resistance patterns of biofilm-forming Pseudomonas aeruginosa isolates from mechanically ventilated patients. International Journal of Scientific Study 2017; 5(5): 84-88. doi: 10.17354/ijssI/2017/106.
  27. Hussein MH, Aal Owaif HA, Abdulateef SA. The Aminoglycoside Resistance Genes, pehX, blaCTX-M, blaAmpC, and npsB among Klebsiella oxytoca Stool Samples. International Journal of Biomedicine. 2023;13(3):127-130. doi:10.21103/Article13(3)_OA13.Top of Form
  28. Santos-Lopez A, Marshall CW, Scribner MR, Snyder DJ, Cooper VS. Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. Elife. 2019 Sep 13;8:e47612. doi: 10.7554/eLife.47612. PMID: 31516122; PMCID: PMC6814407.

Download Article
Received December 5, 2024.
Accepted January 15, 2025.
©2025 International Medical Research and Development Corporation.